【疾病名】十二指肠腺癌【英文名】ADENOCARCINOMA O.doc 【疾病名】十二指肠腺癌【英文名】adenocarcinomaofduodenum【缩写】【别名】adenocarcinomaofdodecadactylonadenocarcinomaofzwolffingerdarm【ICD号】 C17.0【概述】十二指肠腺癌adenocarcinomaofduodenum是指起源于十二指肠黏 膜的腺癌。多为单发可由腺瘤恶变而来。组织学...
Adenocarcinomais a cancer ofmucus-secreting glands, it can occur to any part of the body. It is most prevalent in lung cancer, prostate cancer, pancreatic cancer, esophageal cancer. Adenocarcinoma can diagnose bybiopsy, computerized tomography (CT) scan, magnetic resonance image (MRI). And the ...
Metastasis is the major cause of treatment failure in patients with prostate adenocarcinoma (PRAD). Diverse programmed cell death (PCD) patterns play an important role in tumor metastasis and hold promise as predictive indicators for PRAD metastasis. Usi
Additionally, the mortality rates for pancreatic cancers have been reported to rise annually by 0.3% in males from 2011 to 2015 with no change in females, contrasting with the considerable decline in mortality for the four most common cancers (breast, prostate, lung and colorectal) in the same...
deaths due to events linked to codes V01–X59 in the 10th Revision of the International Classification of Diseases (ICD-10). For the negative control analysis, time of exit was defined as age at the time of death, emigration, loss to follow-up or end of follow-up, whichever came first...
Improving outcomes for New Zealand men with prostate cancer. Prostate cancer (PCa) screening to detect early stage PCa has resulted in increased identification of small-volume, low-grade PCa, many of which meet crite... JN Nacey,B Delahunt,SD Mark - 《New Zealand Medical Journal》 被引量:...
Impact of comorbidity on health-related quality of life after prostate cancer treatment: combined analysis of two prospective cohort studies BJU Int, 114 (2014 Dec), pp. E74-E81 View in ScopusGoogle Scholar 32 H.G. Prigerson, Y. Bao, M.A. Shah, M.E. Paulk, T.W. LeBlanc, B.J. ...
We identified colorectal cancer patients newly registered into the TCDB according to ICD-O-3 (International Classification of Diseases for Oncology, third revision) code C18.0 (cecum)-C21.8 (rectum). Exclusion criteria included patients with stage IV, cancer at anus, pathologic report beyond ...
Moreover, PFKFB4 by reducing prostate cancer cells fructose-2,6-bisphosphate level, make the glucose-6-phosphate guide the PPP, reduces the glycolytic pathway activity, make the NADPH and glutathione levels, eventually reduce the oxidative stress and death of tumor cells, prevent prostate cancer ...
Candidate cases were identified via two parallel pathways: claims interrogation of contracted members (ICD-10 codes: C25.0–C25.9) for the prospective identification of patients OR patient request for a second opinion. The claims-based program, known as Accountable Precision Oncology (APO), runs as...